Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway - PubMed (original) (raw)
Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway
Marie-Hélène Teiten et al. Int J Oncol. 2011 Mar.
Abstract
Activation of the Wingless (Wnt)/ß-catenin signaling pathway contributes to prostate tumorigenesis and metastasis. Depending of the stage of prostate cancer development, current drug therapies are of limited efficiency, so that prevention with natural compounds appears as an attractive strategy especially due to the slow progressive development of prostate cancer. We report here that the chemopreventive agent curcumin from the rhizome of Curcuma longa was able to affect cell proliferation of androgen-dependent prostate cancer through the induction of cell cycle arrest in G2 and modulation of Wnt signaling. Curcumin decreases the level of Tcf-4, CBP and p300 proteins implicated in the Wnt transcriptional complex that leads to the decrease of ß-catenin/Tcf-4 transcriptional activity and of the expression of ß-catenin target genes (cyclin D1 and c-myc). Subsequent cell death induction is linked to autophagy. Interestingly, in androgen-independent prostate cancer cells, curcumin does not affect Wnt/ß-catenin transcriptional activity. Altogether our results suggest that curcumin is an interesting chemopreventive agent for early stage prostate cancer.
Similar articles
- Curcumin interrupts the interaction between the androgen receptor and Wnt/β-catenin signaling pathway in LNCaP prostate cancer cells.
Choi HY, Lim JE, Hong JH. Choi HY, et al. Prostate Cancer Prostatic Dis. 2010 Dec;13(4):343-9. doi: 10.1038/pcan.2010.26. Epub 2010 Aug 3. Prostate Cancer Prostatic Dis. 2010. PMID: 20680030 - Androgen-induced Wnt signaling in preosteoblasts promotes the growth of MDA-PCa-2b human prostate cancer cells.
Liu XH, Kirschenbaum A, Yao S, Liu G, Aaronson SA, Levine AC. Liu XH, et al. Cancer Res. 2007 Jun 15;67(12):5747-53. doi: 10.1158/0008-5472.CAN-07-0478. Cancer Res. 2007. PMID: 17575141 - Androgens and prostate cancer bone metastases: effects on both the seed and the soil.
Yang W, Levine AC. Yang W, et al. Endocrinol Metab Clin North Am. 2011 Sep;40(3):643-53, x. doi: 10.1016/j.ecl.2011.05.001. Endocrinol Metab Clin North Am. 2011. PMID: 21889726 Review. - Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer.
Abd Wahab NA, Lajis NH, Abas F, Othman I, Naidu R. Abd Wahab NA, et al. Nutrients. 2020 Mar 2;12(3):679. doi: 10.3390/nu12030679. Nutrients. 2020. PMID: 32131560 Free PMC article. Review.
Cited by
- KATs in cancer: functions and therapies.
Farria A, Li W, Dent SY. Farria A, et al. Oncogene. 2015 Sep 17;34(38):4901-13. doi: 10.1038/onc.2014.453. Epub 2015 Feb 9. Oncogene. 2015. PMID: 25659580 Free PMC article. Review. - Antitumor agents 290. Design, synthesis, and biological evaluation of new LNCaP and PC-3 cytotoxic curcumin analogs conjugated with anti-androgens.
Shi Q, Wada K, Ohkoshi E, Lin L, Huang R, Morris-Natschke SL, Goto M, Lee KH. Shi Q, et al. Bioorg Med Chem. 2012 Jul 1;20(13):4020-31. doi: 10.1016/j.bmc.2012.05.011. Epub 2012 May 15. Bioorg Med Chem. 2012. PMID: 22672984 Free PMC article. - Enhancing the Anticancer and Anti-Inflammatory Properties of Curcumin in Combination with Quercetin, for the Prevention and Treatment of Prostate Cancer.
Pellegrino M, Bevacqua E, Frattaruolo L, Cappello AR, Aquaro S, Tucci P. Pellegrino M, et al. Biomedicines. 2023 Jul 18;11(7):2023. doi: 10.3390/biomedicines11072023. Biomedicines. 2023. PMID: 37509660 Free PMC article. - Autophagic mechanisms in longevity intervention: role of natural active compounds.
Taban Akça K, Çınar Ayan İ, Çetinkaya S, Miser Salihoğlu E, Süntar İ. Taban Akça K, et al. Expert Rev Mol Med. 2023 Mar 30;25:e13. doi: 10.1017/erm.2023.5. Expert Rev Mol Med. 2023. PMID: 36994671 Free PMC article. Review. - Wnt/β-catenin signaling in cancers and targeted therapies.
Yu F, Yu C, Li F, Zuo Y, Wang Y, Yao L, Wu C, Wang C, Ye L. Yu F, et al. Signal Transduct Target Ther. 2021 Aug 30;6(1):307. doi: 10.1038/s41392-021-00701-5. Signal Transduct Target Ther. 2021. PMID: 34456337 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous